JP2017523985A5 - - Google Patents

Download PDF

Info

Publication number: JP2017523985A5
Authority: JP; Japan
Prior art keywords: seq; acid sequence; amino acid; polypeptide; identity
Prior art date: 2015-08-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2017506294A

Other languages

English (en)

Japanese (ja)

Other versions

JP2017523985A (ja

Filing date

2015-08-05

Publication date

2018-07-19

2015-08-05 Application filed filed Critical

2015-08-05 Priority claimed from PCT/EP2015/068012 external-priority patent/WO2016020413A1/en

2017-08-24 Publication of JP2017523985A publication Critical patent/JP2017523985A/ja

2018-07-19 Publication of JP2017523985A5 publication Critical patent/JP2017523985A5/ja

Status Pending legal-status Critical Current

Links

229920001184 polypeptide Polymers 0.000 claims 20
102000004196 processed proteins & peptides Human genes 0.000 claims 20
108090000765 processed proteins & peptides Proteins 0.000 claims 20
125000003275 alpha amino acid group Chemical group 0.000 claims 18
150000001720 carbohydrates Chemical class 0.000 claims 8
241000194017 Streptococcus Species 0.000 claims 6
101150078778 SPB1 gene Proteins 0.000 claims 4
239000008194 pharmaceutical composition Substances 0.000 claims 4
150000001413 amino acids Chemical class 0.000 claims 3
239000000427 antigen Substances 0.000 claims 2
102000036639 antigens Human genes 0.000 claims 2
108091007433 antigens Proteins 0.000 claims 2
239000012634 fragment Substances 0.000 claims 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
125000001433 C-terminal amino-acid group Chemical group 0.000 claims 1
108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims 1
241000124008 Mammalia Species 0.000 claims 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 1
241000193985 Streptococcus agalactiae Species 0.000 claims 1
108700010638 Streptococcus agalactiae Spb1 Proteins 0.000 claims 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
239000003814 drug Substances 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
230000028993 immune response Effects 0.000 claims 1
230000001939 inductive effect Effects 0.000 claims 1
-1 linker amino acid Chemical group 0.000 claims 1
239000000203 mixture Substances 0.000 claims 1

JP2017506294A 2014-08-05 2015-08-05 抗原用担体分子 Pending JP2017523985A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP14179945.2		2014-08-05
EP14179945		2014-08-05
PCT/EP2015/068012 WO2016020413A1 (en)	2014-08-05	2015-08-05	Carrier molecule for antigens

Publications (2)

Publication Number	Publication Date
JP2017523985A JP2017523985A (ja)	2017-08-24
JP2017523985A5 true JP2017523985A5 (2)	2018-07-19

Family

ID=51298571

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2017506294A Pending JP2017523985A (ja)	2014-08-05	2015-08-05	抗原用担体分子

Country Status (16)

Country	Link
US (1)	US10245310B2 (2)
EP (1)	EP3177324A1 (2)
JP (1)	JP2017523985A (2)
KR (1)	KR20170039709A (2)
CN (1)	CN108064174A (2)
AR (1)	AR101455A1 (2)
AU (1)	AU2015299008B2 (2)
BE (1)	BE1022792B1 (2)
BR (1)	BR112017002183A2 (2)
CA (1)	CA2957118A1 (2)
EA (1)	EA201790239A1 (2)
IL (1)	IL250238A0 (2)
MX (1)	MX2017001638A (2)
SG (1)	SG11201700673RA (2)
WO (1)	WO2016020413A1 (2)
ZA (1)	ZA201700824B (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20110072A1 (es) *	2005-06-27	2011-02-04	Glaxosmithkline Biolog Sa	Composicion inmunogenica
BE1025162B9 (fr)	2016-12-06	2019-01-07	Glaxosmithkline Biologicals Sa	Procede de purification pour les polysaccharides capsulaires
CN110366428B (zh)	2016-12-30	2024-05-17	Vaxcyte公司	具有非天然氨基酸的多肽-抗原缀合物
US11951165B2 (en)	2016-12-30	2024-04-09	Vaxcyte, Inc.	Conjugated vaccine carrier proteins
WO2018187515A1 (en) *	2017-04-04	2018-10-11	Avidea Technologies, Inc.	Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
EP3638301A1 (en)	2017-06-16	2020-04-22	GlaxoSmithKline Biologicals S.A.	Method of treatment
WO2019217665A1 (en) *	2018-05-09	2019-11-14	West Virginia University	Iron-acquisition receptor peptide administration for vaccination against pseudomonas aeruginosa
EP3574915A1 (en) *	2018-05-29	2019-12-04	Neovacs	Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activity
DK3817775T3 (da) *	2018-07-04	2024-09-16	Vaxcyte Inc	Forbedringer i immunogene konjugater
WO2020010000A1 (en) *	2018-07-04	2020-01-09	Sutrovax, Inc.	Improved methods for the preparation of immunogenic conjugates
CN108840914B (zh) *	2018-08-13	2022-07-01	内蒙古民族大学	一种具有免疫原性的多肽、其抗体的制备方法以及用途
KR20210146392A (ko) *	2019-04-02	2021-12-03	박사이트, 인코포레이티드	침습 플라스미드 항원 b의 최적화된 무세포 합성 및 관련 조성물 및 사용 방법
US12533418B2 (en)	2019-11-22	2026-01-27	Glaxosmithkline Biologicals Sa	Dosage and administration of a bacterial saccharide glycoconjugate vaccine
WO2021250626A2 (en) *	2020-06-12	2021-12-16	Glaxosmithkline Biologicals Sa	Dock tag system
WO2021250625A2 (en)	2020-06-12	2021-12-16	Glaxosmithkline Biologicals Sa	Gbs ferritin nanoparticles
CN112979797B (zh) *	2021-04-28	2022-04-01	中国检验检疫科学研究院	一种抗赤羽病病毒单克隆抗体及其制备方法与应用
GB202215634D0 (en) *	2022-10-21	2022-12-07	Glaxosmithkline Biologicals Sa	Polypeptide scaffold

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008508320A (ja)	2004-07-29	2008-03-21	カイロンコーポレイション	Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
JP2008525033A (ja) *	2004-12-22	2008-07-17	ノバルティスヴァクシンズアンドダイアグノスティクス，インコーポレイテッド	Ｂ群連鎖球菌
GB0502095D0 (en) *	2005-02-01	2005-03-09	Chiron Srl	Conjugation of streptococcal capsular saccharides
GB0605757D0 (en) *	2006-03-22	2006-05-03	Chiron Srl	Separation of conjugated and unconjugated components
WO2009027768A2 (en) *	2006-07-26	2009-03-05	Novartis Ag	Immunogenic compositions for gram positive bacteria
GB0802503D0 (en) *	2008-02-11	2008-03-19	Novartis Ag	Hybrid polypeptide
CN103897045A (zh)	2009-01-12	2014-07-02	诺华股份有限公司	抗革兰氏阳性细菌疫苗中的Cna_B结构域
GB201003333D0 (en)	2010-02-26	2010-04-14	Novartis Ag	Immunogenic proteins and compositions
GB201005625D0 (en) *	2010-04-01	2010-05-19	Novartis Ag	Immunogenic proteins and compositions
GB201114923D0 (en)	2011-08-30	2011-10-12	Novartis Ag	Immunogenic proteins and compositions
WO2013124473A1 (en)	2012-02-24	2013-08-29	Novartis Ag	Pilus proteins and compositions

2015
- 2015-08-05 MX MX2017001638A patent/MX2017001638A/es unknown
- 2015-08-05 EA EA201790239A patent/EA201790239A1/ru unknown
- 2015-08-05 US US15/501,474 patent/US10245310B2/en active Active
- 2015-08-05 EP EP15744610.5A patent/EP3177324A1/en not_active Withdrawn
- 2015-08-05 CN CN201580053997.XA patent/CN108064174A/zh active Pending
- 2015-08-05 KR KR1020177005840A patent/KR20170039709A/ko not_active Withdrawn
- 2015-08-05 WO PCT/EP2015/068012 patent/WO2016020413A1/en not_active Ceased
- 2015-08-05 BR BR112017002183-8A patent/BR112017002183A2/pt not_active IP Right Cessation
- 2015-08-05 AR ARP150102512A patent/AR101455A1/es unknown
- 2015-08-05 SG SG11201700673RA patent/SG11201700673RA/en unknown
- 2015-08-05 BE BE2015/5496A patent/BE1022792B1/fr not_active IP Right Cessation
- 2015-08-05 JP JP2017506294A patent/JP2017523985A/ja active Pending
- 2015-08-05 AU AU2015299008A patent/AU2015299008B2/en not_active Expired - Fee Related
- 2015-08-05 CA CA2957118A patent/CA2957118A1/en not_active Abandoned
2017
- 2017-01-23 IL IL250238A patent/IL250238A0/en unknown
- 2017-02-02 ZA ZA2017/00824A patent/ZA201700824B/en unknown

Publication	Publication Date	Title
JP2017523985A5 (2)	2018-07-19
JP2013079285A5 (2)	2013-12-12
JP2012501959A5 (2)	2012-10-11
JP2013504556A5 (2)	2013-09-26
JP2016040284A5 (2)	2016-05-12
IL325353A (en)	2026-02-01	Incretin analogs and their use
JP2015529678A5 (2)	2017-06-08
IL276210B2 (en)	2024-01-01	Mers-cov vaccine
JP2013503110A5 (2)	2013-08-01
RU2017144606A (ru)	2019-03-04	Иммуноцитокины на основе il-15 и il-15rа домена sushi
JP2012126742A5 (2)	2013-05-16
HRP20191852T1 (hr)	2019-12-27	Polipeptidi
JP2016527286A5 (2)	2017-08-24
JP2016512425A5 (2)	2017-04-06
NZ601818A (en)	2014-09-26	Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers
JP2016513638A5 (2)	2016-06-23
JP2019506862A5 (2)	2020-03-12
FI2970398T3 (fi)	2024-08-06	Rsv f -prefuusioproteiineja ja niiden käyttö
JP2015501329A5 (2)	2015-12-24
EP2582719A4 (en)	2013-12-04	Single chain insulin agonists exhibiting high activity at the insulin receptor
JP2012522802A5 (2)	2013-05-23
JP2015518818A5 (2)	2016-06-30
RU2014136401A (ru)	2016-05-10	Композиции neisseria meningitidis и способы их применения
JP2015505309A5 (2)	2015-04-02
JP2006506989A5 (2)	2008-08-21